Tandem Diabetes Care Reports Second Quarter 2015 Financial Results

Go back to Tandem Diabetes Care Reports Second Quarter 2015 Financial Results

Tandem Diabetes (TNDM) Tops Q2 EPS by 6c

July 30, 2015 4:32 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q2 EPS of ($0.65), $0.06 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $15.7 million versus the consensus estimate of $14.92 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

... More